WallStreetZenWallStreetZen

NASDAQ: BGLC
Bionexus Gene Lab Corp Earnings & Revenue

OverviewEarnings
DividendOwnership

BGLC past revenue growth

How has BGLC's revenue growth performed historically?
Company
-10.6%
Industry
0.1%
Market
17.55%
BGLC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BGLC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BGLC's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BGLC earnings and revenue history

Current Revenue
$9.8M
Current Earnings
-$2.6M
Current Profit Margin
-26.9%

BGLC Return on Equity

Current Company
-33%
Current Industry
-24%
Current Market
188%
BGLC's Return on Equity (-33%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BGLC announces earnings.

BGLC Return on Assets

Current Company
-27%
Current Industry
6.7%
BGLC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BGLC Return on Capital Employed

Current Company
-26.55%
Current Industry
11.6%
BGLC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BGLC vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BGLC$9.77M-$2.49M-$2.63M+115.07%N/A
PRPO$15.20M-$4.32M-$5.85M+39.62%N/A
CHEK$0.00-$19.08M-$17.62MN/AN/A
XWEL$30.11M-$24.16M-$27.74M-9.68%N/A
CNTG$55.12M-$44.39M-$61.44M+1.95%N/A
View Top Diagnostic & Research Stocks

Bionexus Gene Lab Earnings & Revenue FAQ

What were BGLC's earnings last quarter?

Bionexus Gene Lab (NASDAQ: BGLC) reported Q4 2023 earnings per share (EPS) of $0.04, up 105.88% year over year. Total Bionexus Gene Lab earnings for the quarter were $308.46 thousand. In the same quarter last year, Bionexus Gene Lab's earnings per share (EPS) was $0.02.

If you're new to stock investing, here's how to buy Bionexus Gene Lab stock.

What was BGLC's earnings growth in the past year?

As of Q2 2024, Bionexus Gene Lab's earnings has grown year over year. Bionexus Gene Lab's earnings in the past year totalled -$2.63 million.

What was BGLC's revenue last quarter?

Bionexus Gene Lab (NASDAQ: BGLC) reported Q4 2023 revenue of $2.27 million up 19.95% year over year. In the same quarter last year, Bionexus Gene Lab's revenue was $2.84 million.

What was BGLC's revenue growth in the past year?

As of Q2 2024, Bionexus Gene Lab's revenue has grown -10.6% year over year. This is 10.7 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 0.1%. Bionexus Gene Lab's revenue in the past year totalled $9.77 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.